CircRNA F-circEA, originating from the EML4-ALK fusion gene, is enriched in the plasma of EML4-ALK-positive non-small cell lung cancer (NSCLC), serving as an additional “liquid biopsy” biomarker for NSCLC [144]. This evidence concerns the gene ALK and non-small cell lung carcinoma.